Showing 11-20 of 26 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Improving Glucose Levels while Preventing Ketoacidosis in People with Type 1 Diabetes Receiving SGLT1/2 inhibitor Therapy Using a Novel Continuous Ketone Sensor (PARTNER) | The University of Melbourne | David O’Neal | Improving Lives | 01-November-2024 to 31-October-2026 | $221,126.00 |
| A synergistic approach to preventing islet allograft rejection in beta cell replacement therapy | St. Vincent’s Institute of Medical Research | Seigmund Lai | Cures | 01-March-2025 to 29-February-2028 | $256,285.00 |
| Monitoring CD4+ T-cell responses in T1D, MS and SLE | St. Vincent’s Institute of Medical Research | Stuart Mannering | Cures | 01-September-2025 to 31-December-2027 | $149,998.36 |
| Harnessing T cell exhaustion for type 1 diabetes prevention | St. Vincent’s Institute of Medical Research | Thomas Kay | Cures | 01-November-2023 to 31-October-2026 | $2,250,000.00 |
| BTM Extension- Alternate cells and biomaterials | Royal Adelaide Hospital | Patrick Coates | Cures | 01-May-2026 to 30-April-2028 | $195,004.00 |
| Engineering an artificial pancreas in the gut for the treatment of diabetes | Monash University | Rong Xu | Improving Lives | 01-September-2025 to 31-August-2028 | $285,000.00 |
| Providing blood glucose monitoring, HbA1c testing, and other in-country support to centers enrolled in the Life for a Child Program | Diabetes Australia NSW | Graham Ogle | Transportfolio | 01-March-2025 to 30-September-2026 | $1,266,667.00 |
| End Diabetes Stigma: Global Summit | Deakin University | Jane Speight | Improving Lives | 01-March-2025 to 28-February-2027 | $500,000.00 |
| Induction of beta-cell regeneration using EZH2 inhibitors | Baker Heart & Diabetes Institute | Sam El-Osta | Cures | 01-October-2023 to 31-August-2026 | $699,447.00 |
| Extracellular Matrix to Maintain Function of Encapsulated Human Stem Cell Differentiated Islets Seeded into Scaffolds: Nude Rat Model | Australian Foundation for Diabetes Research | Bernard Tuch | Cures | 01-January-2026 to 31-December-2026 | $200,000.00 |